UBS Group’s LENZ Therapeutics LENZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $25.8M | Buy |
|
|||||
|
2025
Q1 | $17.2M | Buy |
|
|||||
|
2024
Q4 | $2.48M | Buy |
|
|||||
|
2024
Q3 | $146K | Buy |
|
|||||
|
2024
Q2 | $70.2K | Sell |
|
|||||
|
2024
Q1 | $95.4K | Sell |
|
|||||
|
2023
Q4 | $80.5K | Buy |
|
|||||
|
2023
Q3 | $38.8K | Sell |
|
|||||
|
2023
Q2 | $51.9K | Buy |
|
|||||
|
2023
Q1 | $22K | Buy |
|
|||||
|
2022
Q4 | $5.07K | Hold |
|
|||||
|
2022
Q3 | $5K | Sell |
|
|||||
|
2022
Q2 | $132K | Buy |
|
|||||
|
2022
Q1 | $27K | Sell |
|
|||||
|
2021
Q4 | $98K | Buy |
|
|||||
|
2021
Q3 | $41K | Buy |
|